Peptide of the Week: Industry Update – Retatrutide, GLP-1s & FDA Moves Explained
Welcome back, warriors! In this week’s special episode of Peptide of the Week, JD Denham and William T. Haas are joined by peptide researcher and clinical expert Paul Bakhtiar to break down the biggest developments shaking up the entire peptide industry.
From FDA crackdowns to the future of GLP-1s like Retatrutide, this episode gives you the real insider breakdown of what’s happening, why it matters, and what you should do right now if you’re using or selling peptides.
We cover:
⚠️ Retatrutide: What’s changing & when
– Big Pharma is moving fast to monopolize Retatrutide via FDA approval
–…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.